Home › Alzheimer's Disease › Washington
Alzheimer's Disease clinical trials in Washington
17 studies for Alzheimer's Disease are looking for participants at sites in Washington.
Cities in Washington
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Bellevue
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 29, 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1644, Seattle
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229Dominantly Inherited Alzheimer Network (DIAN)
- University of Washington, Seattle
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT00869817A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Northwest Clinical Research Center, Bellevue
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
RecruitingPhase 2
Ages 55 to 80 · All sexes · Updated Sep 21, 2026 · NCT06847321A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- EvergreenHealth Medical Center, Kirkland
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1644, Seattle
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011732Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- Fred Hutchinson Cancer Center, Seattle
RecruitingObservational studyHealthy volunteers welcomeMentions payment for participants
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT06922188Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Washington Medical Center, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Northwest Clinical Research Center, Bellevue
- Universal Research Group, Tacoma
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Jul 7, 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- University of Washington Medical Center, Seattle
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Jun 26, 2026 · NCT07094516Late Onset Alzheimer's Disease
- University of Washington, Seattle
RecruitingObservational studyHealthy volunteers welcome
Ages 55 and older · All sexes · Updated May 18, 2026 · NCT05010603A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- University of Washington, Seattle
Recruiting
Ages 60 and older · All sexes · Updated Jul 20, 2025 · NCT06411561From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.